Jia Jie Biomedical Co Ltd Working Capital to Net Assets Ratio
Jia Jie Biomedical Co Ltd working capital to net assets ratio. Jia Jie Biomedical Co Ltd (4109) has a Working Capital to Net Assets ratio of 26.5% as of March 2026. Working capital of NT$450.32 Million (current assets of NT$596.42 Million minus current liabilities of NT$146.09 Million) is measured against net assets of NT$1.70 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Jia Jie Biomedical Co Ltd (2015–2025)
Working capital to net assets ratio of Jia Jie Biomedical Co Ltd from 2015 to 2025. This chart shows how Jia Jie Biomedical Co Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 26.5%, reflecting working capital of NT$450.32 Million against net assets of NT$1.70 Billion TWD. Explore 4109 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Jia Jie Biomedical Co Ltd Working Capital to Net Assets Ratio by Year (2015–2025)
Jia Jie Biomedical Co Ltd working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Jia Jie Biomedical Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 4109 total assets.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 23.5% | NT$403.64 Million | NT$1.71 Billion | NT$574.48 Million | NT$170.84 Million | ▲ +6.5 pp |
| 2024 | 17.0% | NT$231.49 Million | NT$1.36 Billion | NT$348.34 Million | NT$116.85 Million | ▲ +7.6 pp |
| 2023 | 9.4% | NT$100.47 Million | NT$1.07 Billion | NT$437.31 Million | NT$336.84 Million | ▼ -17.0 pp |
| 2022 | 26.4% | NT$243.69 Million | NT$923.96 Million | NT$317.21 Million | NT$73.52 Million | ▼ -1.3 pp |
| 2021 | 27.6% | NT$258.36 Million | NT$934.93 Million | NT$340.28 Million | NT$81.93 Million | ▼ -5.5 pp |
| 2020 | 33.1% | NT$300.42 Million | NT$907.97 Million | NT$379.73 Million | NT$79.31 Million | ▲ +26.2 pp |
| 2019 | 6.9% | NT$47.61 Million | NT$694.88 Million | NT$186.64 Million | NT$139.03 Million | ▲ +1.9 pp |
| 2018 | 5.0% | NT$35.58 Million | NT$714.19 Million | NT$425.02 Million | NT$389.44 Million | ▲ +34.1 pp |
| 2017 | -29.2% | NT$-203.99 Million | NT$699.60 Million | NT$389.25 Million | NT$593.25 Million | ▼ -38.8 pp |
| 2016 | 9.6% | NT$92.40 Million | NT$962.54 Million | NT$492.40 Million | NT$400.00 Million | ▼ -0.9 pp |
| 2015 | 10.5% | NT$103.36 Million | NT$983.23 Million | NT$440.85 Million | NT$337.48 Million | — |